Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
CVRx (United States)
h-index: 29
Total citations: 3,621
Total papers: 103
Homepage:
http://www.cvrx.com/
Recent papers from CVRx (United States)
Ambulatory hemodynamic changes following baroreflex activation therapy measured by an implantable pulmonary artery pressure sensor
Journal of Cardiology Cases · 2026
Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure Trial
JACC Heart Failure · 2024
Baroreflex Activation Therapy in HFrEF: Anti-Inflammatory Effects and Autonomic Restoration
JACC Case Reports · 2026
Final Response to Authors of “Experimental Evaluation of Relationship Between Radiofrequency Heating Near Implanted Conductive Devices, Scanner-Reported B 1+rms , and Transmit Power”
IEEE Journal of Microwaves · 2026
Comments on “Experimental Evaluation of Relationship Between Radiofrequency Heating Near Implanted Conductive Devices, Scanner-Reported B 1+rms , and Transmit Power”
IEEE Journal of Microwaves · 2026
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model
Journal of Neuroinflammation · 2025
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long‐term outcomes
European Journal of Heart Failure · 2024
Leveraging Patient Preference Information in Medical Device Clinical Trial Design
Therapeutic Innovation & Regulatory Science · 2022
Baroreflex activation therapy with the Barostim ™ device in patients with heart failure with reduced ejection fraction: a patient level meta‐analysis of randomized controlled trials
European Journal of Heart Failure · 2022
Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study
Circulation Heart Failure · 2021
Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure
JACC Heart Failure · 2021
Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States
BMC Cardiovascular Disorders · 2021
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology · 2020
Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
Nature Communications · 2019
First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF
American Heart Journal · 2018
Non-clinical and Pre-clinical Testing to Demonstrate Safety of the Barostim Neo Electrode for Activation of Carotid Baroreceptors in Chronic Human Implants
Frontiers in Neuroscience · 2017
An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems
Journal of the American Society of Hypertension · 2016
Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension
Hypertension · 2016
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction
Seminars in Thoracic and Cardiovascular Surgery · 2016
Long-term chronic baroreflex activation
Journal of Hypertension · 2015